Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 24, 1994-1996, December 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riggins, R. S.
Right arrow Articles by Pilch, Y. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riggins, R. S.
Right arrow Articles by Pilch, Y. H.

Immunity to Spontaneous and Methylcholanthrene-induced Tumors in Inbred Mice

Richard S. Riggins* and Yosef H. Pilch{dagger}

( Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland)

Inbred C3H/HEN mice were shown to develop a specific immunity to a spontaneously arising adenocarcinoma as well as to a methylcholanthrene-induced fibrosarcoma when the tumors were allowed to grow temporarily in their hind limb. The resistance in the spontaneous carcinoma system was less than in the fibrosarcoma system. In each case the immunity produced was specific for the immunizing tumor, and no cross-immunity was observed. Animals challenged shortly after removal of their immunizing tumor and animals in which the immunizing tumor was not removed did not exhibit any resistance toward a second tumor transplant.

Whether other spontaneous mammary carcinomas and methylcholanthrene-induced sarcomas will behave similarly requires further investigation. The results reported in this paper may apply only to the specific tumors studied.

* Present address: The Campbell Clinic, Memphis, Tenn.

{dagger} Present address: Department of Surgery, Albert Einstein College of Medicine, Bronx, N. Y.

Received 7/10/64.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1964 by the American Association for Cancer Research.